Pharmacology of spinal cord injury: Basic mechanism of action and side effects of commonly used drugs

Neurology Report

Volumn 27, Issue 3, 2003, Pages 101-108

  Scelza, William ^a   Shatzer, Matthew ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350230314     PISSN: 1085049X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01253086-200327030-00004     Document Type: Article

References (47)

1. National Spinal Cord Injury Statistical Center Statistics at a Glance. Available at: http://www.spinalcord.uab.edu. Accessed May 1,2001.
2. Teasell RW, Arnold JM, Krassioulkov A. Cardiovascular consequences of loss of supraspinal control of the sym-pathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000;81 (4): 506-516.
3. Braddom RL, Rocco JF. Autonomic dysreflexia: a survey of current treatment. Am J Phys Med Rehabil. 1991; 70:234-241.
4. Linsenmeyer TA, Campagnolo DI, Chou IH. Silent autonomic dysreflexia during voiding in men with spinal cord injuries. J Urol. 1996;155:519-522.
5. Clinical Practice Guidelines:Acute management of autonomie dysreflexia. J Spinal Cord Med. 1997;20:284-318.
6. Barber DB, Rogers SJ, Fredrickson MD, et al. Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature. Spinal Cord. 2000;38:109-111.
7. Campagnolo DI, Merli G. Autonomie and cardiovascular complications of spinal cord in jury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott; 2002:123-134.
8. Merli G, Herbison, G, Ditunno J, et al. Deep venous thrombosis: prophylaxis in acute spinal cord injured subjects. Arch Phys Med Rehabil. 1988;69:661-664.
9. Virchow R. Neurer fall von tödlichen: emboli der lun-genaterie. Arch Pathol Anat. 1856;10:225-228.
10. Harker LA. Antithrombotic therapy. In: Goldman L, Bennett JC, eds. Cecil’s Textbook of Medicine. 21st ed. Philadelphia, Pa: WB Saunders; 2000:1021-1028.
11. Yezierski RP, Pain fbllowing spinal cord injury: the clinicai problem and experimental studies. Pain. 1996;68: 185-194.
12. Bonica, Introduction: semantic, epidemiologic, and edu-cational issues. In: Casey KL, ed. Pain and Central Nervotis System Sisease, The Central PainSyndromes, New York, NY: Raven Press; 1991.
13. Richards JS, Stover SL, Jaworski T. Effect of bullet removal on subsequent pain in persons with spinal cord injury secondary to gunshot wound. J Neurosurg. 1990;73:401-404.
14. Fenellosa P, Pallares J, Cervera J, et al. Chronic pain in the spinal cord injured: statistical approach and pharmaco-logical treatment. Paraplegia. 1993;31:722-729.
15. Stitik TP, Klecz R, Zafonte RO, et al. Pharmacotherapy of disability. In: DeLisa JA, Gans BM, ed. Rehabilitation Medicine: Principies and Practice. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:789-828.
16. Cioni B, Meglio M, Pentimalli L, et al. Spinal cord stimulation in the treatment of paraplegie pain. J Pain Symptom Manage. 1995;82(1):35-39.
17. Chesnut C, Baylink D, Doyle H, et al. Salmon-calcitonin nasal spray prevents vertebral fractures, in established osteoporosis. Further interim trials of the “PROOF” study. ECO Abstract, OP INT. 1998:813.
18. Hawkins C, Hanks GW. The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature. J Pain Symptom Manage. 2000;20:140-151.
19. Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover triai. J Spinal Cord Med. 2002;25(2) 100-105.
20. Sandford PR, Lindblom LB, Haddox JD. Amitriptyline and carbamazepime in the treatment of dysesthetic pain in spinal cord injury. Arcb Phys Med Rehabil. 1992;73(3):300-301.
21. Anghene P, van Houdenkove B. Antidepressant-induced analgesia in chronic non-malignant pain: a metaanalysis of 39 placebo controlled studies. Headache. 1994; 34:44-49.
22. Fuhrer MJ, Rintala DH, Hart KA, Clearman R, Young ME. Depressive symptomatology in persons with spinal cord injury who reside in the community. Arch Phys Med Rehabil. 1993;74:255-260.
23. Heinemann AW. Spinal cord injury. In: Goreczny AJ, ed. Handbook of Health and Rehabilitation Psychology. New York, NY: Plenum Press; 1995;341-360.
24. Hartkopp A, Bronnum-Hansen H, Seidenschnur AM, Biering-Sorensen F. Suicide in a spinal cord injured population: its relation to functional status. Arch Phys Med Rehabil. 1998;79:1356-1361.
25. Consortium for Spinal Cord Medicine, Depression Foliowing Spinal Cord Injury: A clinical practice guide-line for primary care physicians. Paralyzed Veterans of America.August, 1998.
26. Fichtenbaum J, Kirshblum S. Psychologie adaptation to spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott; 2002:299-311.
27. Consortium for Spinal Cord Medicine. Depression Foliowing Spinal Cord Injury: A Clinical Practice Guideline for Primary Care Physicians. New York, NY: Paralyzed Veterans of America; 1998.
28. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago, 111: Mosby Year Book; 1980:17-24.
29. Maynard FM, Karunas R, Waring WW. Epidemiology of spasticity’ foliowing traumatic spinal cord injury. Arch Phys Med Rehabil. 1990;71:566-569.
30. Kirshblum S. Treatment alternatives for spinal cord injury related spasticity. J Spinal Cord Med. 1999;22(3): 199-217.
31. Rivas DA, Chancellor MB, Hill K, et al. Neurological manifestations of baclofen withdrawal. J Urol. 1993; 150(6): 1903-1905.
32. Zafonte RD, Elovic E. Dual diagnosis: traumatic brain injury in a person with spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott; 2002:261-274.
33. Priebe MM, Goetz LL, Wuermser IA. Spasticity foliowing spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:221-233.
34. Herman R, Mayer N, Mecomber SA.The pharmacophys-iology of dantrolene sodium. Am J Phys Med. 1972; 51:296-311.
35. Banovac K, Gonzalez F. Evaluation and management of heterotopic ossification in patients with spinal cord injury. Spinal Cord. 1997;35:158-162.
36. Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop Related Res. 1991;263:13-29-
37. Stover SL, Hataway CJ, Zeiger HE. Heterotopic ossification in spinal cord-injured patients. Arch Phys Med Rehabil. 1975;56:199-204.
38. Francis MD, Russell RGG, Fleisch H. Disphosplionates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969; 165:1964-1966.
39. Stover SL, Hahn HR, Miller JM. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report). Paraplegia. 1976;14:146-156.
40. Wyndale JJ. Pharmacotherapy for urinary bladder dysfunction in spinal cord injury patients. Paraplegia. 1990;28:146-150.
41. Linsenmeyer TA. Neurogenic bladder following spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott; 2002:181-206.
42. Baldessarini RJ. Drugs and the treatment of psychiatrie disorders. In: Gilman AG, Rail TW, Nies AS, et al, eds. Goodman and Gilman’s The PharmacologicalBasis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990:383-435.
43. Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury: I. Voiding Dysfunction. J Urol. 1978;119:480-482.
44. Stone JM, Nino-Murcia M, Wolfe VA, et al. Chronic gastrointestinal problems in spinal cord injury patients: a prospective analysis. Am J Gastroenterology. 1990;85: 1114-1119.
45. Chen D, Nussbaum SB. Gastrointestinal disorders. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott; 2002:155-163.
46. Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhea. Drug Saf. 1994;10:47-65.
47. House JG, Stiens SA. Pharmacologically initiated defecation of persons with spinal cord injury: effectiveness of three agents. Arch Phys Med Rehabil. 1997;78:1062-1065.